ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 289922 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 289922; 2) Community: the network communities that were significantly associated with the response to NSC 289922; 3) Molecule: the relationships between components within communities and NSC 289922; 4) MDR: the compounds that were significantly associated with the NSC 289922.

NSC Compound Enrichment Correlation
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.0454469012959173 0.67198248
NSC 750762 2-methoxy-7-benzyl-3-(phenylsulfonyl)-6,7-dihydro-5H-pyrazolo[3,4-h]quinoline 0.0454469012959173 0.023719642
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0454469012959173 0.025851198
NSC 755465 Null 0.0454469012959173 -0.056563719
NSC 759274 ARSENIC TRIOXIDE 0.0454469012959173 0.12444623
NSC 763564 EMD-534085 0.0454469012959173 0.43100817
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0454469012959173 0.5434925
NSC 87500 Solacongestidine 0.0454469012959173 0.061118727
NSC 718368 Null 1.12445458734372e-005 0.83338265
NSC 756188 GSK718429A 2.16417361041572e-005 0.03963962
Total:103  Current:102    [First] [Prev] [Next] [Last]